venBio Select Advisor »

Rocket Pharmaceuticals shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2023-12-31 $38M 1.3M 29.97
2023-09-30 $26M 1.3M 20.49
2019-09-30 $3.3M 286k 11.65
2019-06-30 $4.3M 286k 15.00

More positions owned by venBio Select Advisor

Apellis Pharmaceuticals Common (APLS)
United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Argenx Se Sponsored ADR (ARGX)
Madrigal Pharmaceuticals Common (MDGL)
Sarepta Therapeutics Common (SRPT)
Biomarin Pharmaceutical Common (BMRN)
Spdr Series Trust - S&p Biotech Etf (XBI)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Krystal Biotech Common (KRYS)
Mirati Therapeutics Common
Cymabay Therapeutics Common
Xenon Pharmaceuticals Common (XENE)
Alnylam Pharmaceuticals Common (ALNY)

View all positions for venBio Select Advisor

Top funds holding Rocket Pharmaceuticals

Wellington Management Company
Vanguard Group
Maverick Capital
Westfield Capital Management Company
T. Rowe Price Associates
Citadel Advisors
Avidity Partners Management
Perceptive Advisors
Frazier Life Sciences Management
Boxer Capital
Logos Global Management
venBio Select Advisor
Cowen And Company
Franklin Resources
Bamco

View all funds holding Rocket Pharmaceuticals